Research Portfolio

Funding Opportunities

Join our Mailing List
Join our mailing list to be notified of new funding opportunities.

Your Email

To receive information about funding opportunities, events, and program updates.



Ching-Hsien Chen, Ph.D.

University of California, Davis # of Grants: 2

Grants

Targeting phospho-MARCKS in smoke-mediated lung cancer 2014 (Cycle 23) $91,436
Early Diagnosis/Pathogenesis Postdoctoral Fellowship Awards

Tackling Stem-Like Cells in Tobacco Smoke-Mediated Cancer Ma 2018 (Cycle 27) $750,000
Unknown New Investigator Awards

Therapeutic targeting to inhibit lung fibrosis progression 2019 (Cycle 28) $925,286
Unknown High Impact Research Project Award
Publications

Targeting myristoylated alanine-rich C kinase substrate phosphorylation site domain in lung cancer. Mechanisms and therapeutic implications
Periodical: Index Medicus:
Authors: Chen CH, Statt S, Chiu CL, et al ART
Yr: Vol: Nbr: Abs: Pg:

Elevated MARCKS phosphorylation contributes to unresponsiveness of breast cancer to paclitaxel treatment
Periodical: Index Medicus:
Authors: Chen CH, Cheng CT, Yuan Y, et al ART
Yr: Vol: Nbr: Abs: Pg:

HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual_x000D_ mechanisms
Periodical: Index Medicus:
Authors: Chen CH, Chang WH, Su KY, Ku WH, Chang GC, Hong QS, Hsiao YJ, Chen HC, Chen HY, Wu R, Yang ART
Yr: Vol: Nbr: Abs: Pg: